NCT02172963View on ClinicalTrials.gov

A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Hemorrhagic Cystitis
Interventions
BIOLOGICAL

Decidual Stromal Cell therapy

Intravenous injection with placenta derived Decidual Stromal Cells. 1-2x10\^6 cells/kg.

Trial Locations (1)

14186

Karolinska Institutet, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT02172963 - A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis | Biotech Hunter | Biotech Hunter